Cell Signaling Technology

Product Pathways - Apoptosis / Autophagy

AP-2α Antibody #3208

Applications Reactivity MW (kDa) Source
W IP IHC-P IF-IC H M R Mk 48 Rabbit

Applications Key:  W=Western Blotting  IP=Immunoprecipitation  IHC-P=Immunohistochemistry (Paraffin)  IF-IC=Immunofluorescence (Immunocytochemistry)
Reactivity Key:  H=Human  M=Mouse  R=Rat  Mk=Monkey
Species enclosed in parentheses are predicted to react based on 100% sequence homology. Species cross-reactivity is determined by Western blot.

Specificity / Sensitivity

AP-2α Antibody detects endogenous levels of total AP-2α protein.

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide (KLH-coupled) derived from a sequence of human AP-2α. Antibodies are purified by protein A and peptide affinity chromatography.

Western Blotting

Western Blotting

Western blot analysis of extracts from various cell lines, using AP-2α Antibody.

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human colon carcinoma, using AP-2alpha Antibody.

IHC-P (paraffin)

IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human lung carcinoma, using AP-2alpha Antibody.


IF-IC

IF-IC

Confocal immunofluorescent analysis of HeLa cells labeled with AP-2alpha Antibody (green, left) compared to a nonspecific negative control antibody (right). Actin filaments have been labeled with Alexa Fluor® 555 phalloidin (red). Blue pseudocolor = DRAQ5™ (fluorescent DNA dye).

Background

The sequence-specific transcription factor activator protein 2α (AP-2α) is required for normal growth and morphogenesis during mammalian development (1,2). Decreased or loss of AP-2α expression has been observed in many different types of human cancers including breast cancer (3,4), ovarian cancer (5), melanoma (6) and prostate cancer (7). These findings suggest that AP-2α expression plays a crucial role in tumorigenicity. Studies have also shown that p53 overexpression in human breast carcinoma cells induces the level of AP-2α expression. Furthermore, p53 binds to the cis-element in the AP-2α promoter, suggesting that AP-2α is a target of p53. AP-2α may mediate the effect of p53 to inhibit cell proliferation (8).

  1. Mitchell, P.J. et al. (1987) Cell 50, 847-61.
  2. Williams, T. and Tjian, R. (1991) Genes Dev 5, 670-82.
  3. Douglas, D.B. et al. (2004) Cancer Res 64, 1611-20.
  4. Gee, J.M. et al. (1999) J Pathol 189, 514-20.
  5. Anttila, M.A. et al. (2000) Br J Cancer 82, 1974-83.
  6. Jean, D. et al. (1998) J Biol Chem 273, 16501-8.
  7. Ruiz, M. et al. (2004) Cancer Res 64, 631-8.
  8. Li, H. et al. (2006) Oncogene 25, 5405-15.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

Product Pathways

Drug Discovery Tools

Featured Technologies

Protein Classes